Paediatric liver transplantation for metabolic disorders. Part 2: Metabolic disorders with liver lesions.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Clinics And Research in Hepatology and Gastroenterology

• Publication date

  2011-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.clinre.2011.01.008PMID 21376696
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nitisinone in the Treatment of Hereditary Tyrosinaemia Type 1

  2012cited by this paper
• Treatment for mitochondrial disorders.

  2012cited by this paper
• Ex Vivo Transduction and Transplantation of Bone Marrow Cells for Liver Gene Delivery of α1-Antitrypsin.

  2010cited by this paper
• High volume naked DNA tail‐vein injection restores liver function in Fah‐knock out mice

  2010cited by this paper
• Polymerase Gamma 1 Mutations: Clinical Correlations

  2010cited by this paper
• Hepatobiliary disease in patients with cystic fibrosis

  2009cited by this paper
• Bile salt–induced pro‐oxidant liver damage promotes transplanted cell proliferation for correcting Wilson disease in the Long‐Evans Cinnamon rat model

  2009cited by this paper
• Gene targeted therapeutics for liver disease in alpha-1 antitrypsin deficiency

  2009cited by this paper
• Triethylene tetramine dihydrochloride (trientine) in children with Wilson disease: experience at King’s College Hospital and review of the literature

  2009cited by this paper
• Selection of cystic fibrosis patients for lung transplantation

  2008cited by this paper
• Lung transplantation and survival in children with cystic fibrosis: Solid statistics – Flawed interpretation

  2008cited by this paper
• Liver transplantation for fulminant Wilson's disease in children.

  2008cited by this paper
• Renal tubular function in children with tyrosinaemia type I treated with nitisinone

  2008cited by this paper
• Liver transplantation in children with glycogen storage disease: Controversies and evaluation of the risk/benefit of this procedure

  2008cited by this paper
• NTBC treatment in tyrosinaemia type I: Long-term outcome in French patients

  2008influential reference
• Outcome of Pregnancies at Risk for Neonatal Hemochromatosis Is Improved by Treatment With High-Dose Intravenous Immunoglobulin

  2008cited by this paper
• Alpha-1-antitrypsin deficiency: outcomes after liver transplantation.

  2008cited by this paper
• Emergency Liver Transplantation in Neonates With Acute Liver Failure: Long-Term Follow-Up

  2008cited by this paper
• Augmentation therapy for emphysema due to alpha-1-antitrypsin deficiency

  2008cited by this paper
• Liver Disease Associated with ZZ α1-Antitrypsin Deficiency and Ursodeoxycholic Acid Therapy in Children

  2008cited by this paper
• Fast track recovery following en bloc heart-lung-liver transplantation in a patient with cystic fibrosis complicated by severe portal hypertension.

  2008cited by this paper
• Liver disease in cystic fibrosis

  2007cited by this paper
• Gene therapy for liver enzyme deficiencies: what have we learned from models for Crigler–Najjar and tyrosinemia?

  2007cited by this paper
• Mitochondrial DNA depletion is a prevalent cause of multiple respiratory chain deficiency in childhood.

  2007cited by this paper
• Alpha One Antitrypsin Deficiency: From Gene to Treatment

  2007cited by this paper
• Thinking outside the cell: the role of extracellular adenosine triphosphate in bile formation.

  2007cited by this paper
• Liver disease in mitochondrial disorders.

  2007cited by this paper
• Mitochondrial hepatopathies: Advances in genetics and pathogenesis

  2007cited by this paper
• Wilson's disease

  2007cited by this paper
• Is exchange transfusion a possible treatment for neonatal hemochromatosis?

  2007influential reference
• Renal function in tyrosinaemia type I after liver transplantation: A long-term follow-up

  2006cited by this paper
• Mitochondrial respiratory chain deficiencies expressing the enzymatic deficiency in the hepatic tissue: a study of 31 patients.

  2006cited by this paper
• Fetal and infantile hemochromatosis

  2006cited by this paper
• Hepatocellular carcinoma in a 12‐year‐old child with PiZZ α1‐antitrypsin deficiency

  2006cited by this paper
• Normal Glomerular Filtration Rate in Long-Term Follow-up of Children after Orthotopic Liver Transplantation

  2006cited by this paper
• Neonatal Hemochromatosis: Long-term Experience With Favorable Outcome

  2006cited by this paper
• Alpha-1-antitrypsin deficiency resulting in a hitherto unseen presentation of hepatocellular carcinoma: polycythemia but with normal alpha fetoprotein.

  2006cited by this paper
• Treatment for mitochondrial disorders.

  2006cited by this paper
• Liver Disease in Cystic Fibrosis

  2006cited by this paper
• Liver transplant in cystic fibrosis: a poll among European centers. A study from the European Liver Transplant Registry

  2006cited by this paper
• POLG mutations in Alpers syndrome

  2005cited by this paper
• Living Donor Liver Transplantation for Pediatric Patients with Inheritable Metabolic Disorders

  2005cited by this paper
• Infantile hepatocerebral syndromes associated with mutations in the mitochondrial DNA polymerase-gammaA.

  2005cited by this paper
• Liver transplantation for tyrosinemia

  2005cited by this paper
• Wilson's disease in children: 37‐Year experience and revised King's score for liver transplantation

  2005cited by this paper
• Neonatal hemochromatosis — medical treatment vs. transplantation: The king's experience

  2005influential reference
• Hepatocellular carcinoma in association with cirrhosis in a patient with cystic fibrosis.

  2004influential reference
• Hepatobiliary complications of cystic fibrosis

  2004cited by this paper
• Increased prevalence of CFTR mutations and variants and decreased chloride secretion in primary sclerosing cholangitis

  2003cited by this paper
• Liver transplantation for cholestasis associated with cystic fibrosis in the pediatric population

  2003cited by this paper
• Extensive changes in liver gene expression induced by hereditary tyrosinemia type I are not normalized by treatment with 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione (NTBC).

  2003influential reference
• α1-Antitrypsin deficiency, liver disease and emphysema

  2003cited by this paper
• Liver transplantation for Wilson's disease.

  2003cited by this paper
• Alpha(1)-antitrypsin deficiency, liver disease and emphysema.

  2003cited by this paper
• Liver transplantation in children with cystic fibrosis: a long-term longitudinal review of a single center's experience.

  2003cited by this paper
• Progress in treatment and outcome for children with neonatal haemochromatosis

  2003cited by this paper
• Liver transplantation for Wilson s disease: our experience with review of the literature.

  2003cited by this paper
• Neonatal hemochromatosis.

  2003cited by this paper
• Diseases of the liver and biliary system in children

  2003cited by this paper
• Chances and shortcomings of adenovirus-mediated ATP7B gene transfer in Wilson disease: Proof of principle demonstrated in a pilot study with LEC rats

  2002cited by this paper
• Transplantation for cystic fibrosis: Outcome following early liver transplantation

  2002cited by this paper
• Alpha-1 antitrypsin deficiency

  2001cited by this paper
• Epidemiology and treatment of mitochondrial disorders.

  2001cited by this paper
• Long-term Prospective Study of the Effect of Ursodeoxycholic Acid on Cystic Fibrosis-related Liver Disease

  2001cited by this paper
• Cholangiocyte Biology and Cystic Fibrosis Liver Disease

  2001cited by this paper
• Tyrosinemia: A Review

  2001cited by this paper
• Orthotopic liver transplantation for mitochondrial respiratory chain disorders: a study of 5 children.

  2001cited by this paper
• Chances and shortcomins of adenovirus-mediated ATP7B gene transfer in Wilson disease: proof of principle demonstrated in a pilot study with LEC rats.

  2001cited by this paper
• Clinical spectrum and diagnosis of mitochondrial disorders.

  2001cited by this paper
• Correction of liver disease following transplantation of normal rat hepatocytes into Long-Evans Cinnamon rats modeling Wilson's disease.

  2001cited by this paper
• Liver disease in children

  2001cited by this paper
• Liver transplantation for alpha-1-antitrypsin deficiency in children

  2000cited by this paper
• Nontransplant treatment of tyrosinemia.

  2000cited by this paper
• In vivo selection of hepatocytes transduced with adeno-associated viral vectors.

  2000cited by this paper
• Application of ursodeoxycholic acid (UDCA) in the therapy of liver and biliary duct diseases in children.

  2000cited by this paper
• Inappropriate liver transplantation in a child with Alpers–Huttenlocher syndrome misdiagnosed as valproate‐induced acute liver failure

  2000cited by this paper
• End-stage liver disease as the only consequence of a mitochondrial respiratory chain deficiency: no contra-indication for liver transplantation

  2000cited by this paper
• Mitochondrial DNA Depletion in Children

  2000cited by this paper
• Outcome of cystic fibrosis-associated liver cirrhosis: management of portal hypertension.

  1999cited by this paper
• Recommendations for management of liver and biliary tract disease in cystic fibrosis. Cystic Fibrosis Foundation Hepatobiliary Disease Consensus Group.

  1999cited by this paper
• Mitochondrial respiratory chain disorders and the liver.

  1999cited by this paper
• Heteropolymerization of S, I, and Z alpha1-antitrypsin and liver cirrhosis.

  1999cited by this paper
• Indications and outcome of liver transplantation in tyrosinaemia type 1

  1999cited by this paper
• Biliary excretion of copper in LEC rat after introduction of copper transporting P‐type ATPase, ATP7B

  1999cited by this paper
• Heteropolymerization of S, I, and Z α1-antitrypsin and liver cirrhosis

  1999cited by this paper
• Liver transplantation in mitochondrial respiratory chain disorders

  1999cited by this paper
• Liver transplantation in the first three months of life.

  1998cited by this paper
• Liver failure associated with mitochondrial DNA depletion.

  1998cited by this paper
• A two‐year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis–associated liver disease

  1998cited by this paper
• Generalised mitochondrial cytopathy is an absolute contraindication to orthotopic liver transplant in childhood.

  1998cited by this paper
• Combined heart‐lung‐liver, double lung‐liver, and isolated liver transplantation for cystic fibrosis in children

  1997cited by this paper
• Incidence, population, and survival of cystic fibrosis in the UK, 1968–95

  1997cited by this paper
• Can the histologic changes of cystic fibrosis-associated hepatobiliary disease be predicted by clinical criteria?

  1997cited by this paper
• Liver transplantation: treatment of choice for hepatic and neurological manifestation of Wilson's disease.

  1997cited by this paper
• Young adults with α1antitrypsin deficiency identified neonatally: their health, knowledge about and adaptation to the high‐risk condition

  1997cited by this paper
• Adenovirus-Mediated Gene Therapy in a Mouse Model of Hereditary Tyrosinemia Type I

  1997cited by this paper
• Neonatal and delayed-onset liver involvement in disorders of oxidative phosphorylation.

  1997cited by this paper
• Depletion of mitochondrial deoxyribonucleic acid in a family with fatal neonatal liver disease.

  1996cited by this paper
• Ursodeoxycholic acid for liver disease associated with cystic fibrosis: A double‐blind multicenter trial

  1996cited by this paper
• Neonatal cholestasis as the presenting feature in cystic fibrosis.

  1996cited by this paper

• Use of an oversized AAV8 vector for CPS1 deficiency results in long-term survival and ammonia control

  2025cites this paper
• Characterization of a novel conditional knockout mouse model to assess efficacy of mRNA therapy in the context of severe ornithine transcarbamylase deficiency.

  2025cites this paper
• Long-term outcomes in pediatric patients who underwent living donor liver transplantation for biliary atresia.

  2022cites this paper
• Modelling urea cycle disorders using iPSCs

  2022cites this paper
• Outcomes After Living Donor Liver Transplantation in Pediatric Patients with Inherited Metabolic Diseases

  2021cites this paper
• Living related Liver Transplantation for Metabolic Liver Diseases in Children.

  2020cites this paper
• Evolving Trends in Liver Transplant for Metabolic Liver Disease in the United States

  2019cites this paper
• Chapter 6.3. Studies on Hepatic Metabolic Disorders Driven by ESPGHAN Members

  2018cites this paper
• Pediatric Liver Transplantation: Unique Concerns for the Critical Care Team

  2016cites this paper
• Long-term outcomes in Ornithine Transcarbamylase deficiency: a series of 90 patients

  2015cites this paper
• AASLD PRACTICE GUIDELINE Evaluation of the Pediatric Patient for Liver Transplantation: 2014 Practice Guideline by the American Association for the Study of Liver Diseases, American Society of Transplantation and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition

  2014cites this paper
• Evaluation of the pediatric patient for liver transplantation: 2014 practice guideline by the american association for the study of liver diseases, american society of transplantation and the north american society for pediatric gastroenterology, hepatology and nutrition

  2014cites this paper
• Liver transplantation for lethal genetic syndromes: a novel model of personalized genomic medicine.

  2013cites this paper
• Metabolic liver disease.

  2012cites this paper
• Liver transplantation in children

  1991cites this paper